✦ LIBER ✦

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen

✍ Scribed by Jang, Eun Ryoung; Lim, Soo-Jeong; Lee, Eun Sook; Jeong, Gajin; Kim, Tae-You; Bang, Yung-Jue; Lee, Jong-Soo

Book ID: 110068395
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 337 KB
Volume: 23
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1207315

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen receptor-negative breast cancer

Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid

✍ M. Saeed Sheikh; Zhi-Ming Shao; Jian-Chyi Chen; Arif Hussain; Anton M. Jetten; J 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 968 KB

We and others have shown previously that retinoic acid (RA) selectively inhibits the growth of estrogen receptor (ER)-positive human breast carcinoma (HBC) cells and ER-negative cells are refractory to RA inhibition o f growth. The ER-negative cells inherently express lower levels of RARa and retino

Antineoplastic action of 5-aza-2′-deoxyc

Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells

✍ Veronica Bovenzi; Richard L. Momparler 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 143 KB

Targeting the receptor tyrosine kinase R

Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance

✍ Plaza-Menacho, I; Morandi, A; Robertson, D; Pancholi, S; Drury, S; Dowsett, M; M 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 943 KB